{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T05:08:26Z","timestamp":1775452106379,"version":"3.50.1"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pediatric cancer programs in low\u2010income countries (LIC) can improve outcomes. However, treatment must be tailored to the patient's living conditions and the availability of supportive care. In some cases, a more intense regimen will decrease survival since the increase in death from toxicity may exceed any decrease in relapse. Attempts to practice evidence\u2010based pediatric oncology are thwarted by the lack of evidence derived from local experience in LIC to determine optimal therapy. This report summarizes treatment regimens used by pediatric oncologists from 15 countries of the Caribbean, Central and South America who participate in the Monza International School of Pediatric Hematology\/Oncology (MISPHO). Patients with hepatoblastoma, Wilms tumor, and histiocytosis treated on unmodified published protocols had outcomes comparable to those in high\u2010income countries (HIC). Those with rhabdomyosarcoma, osteosarcoma, Hodgkin lymphoma, and acute myeloid leukemia treated with unmodified regimens had event\u2010free survival estimates 10%\u201320% lower than those reported in HIC due to higher rates of toxic death, abandonment of therapy, and relapse. Treatment of retinoblastoma is complicated by advanced stages and extraocular disease at diagnosis; improved outcomes depend on education of pediatricians and the public to recognize early signs of this disease. Use of unmodified protocols for Burkitt lymphoma and acute lymphoblastic leukemia have been associated with unacceptable toxicity in LIC, so MISPHO centers have modified published regimens by giving lower doses of methotrexate and reducing use of anthracyclines. Despite the use of all\u2010trans\u2010retinoic acid during induction for acute promyelocytic leukemia, the incidence of fatal hemorrhage remains unacceptably high. Pediatr Blood Cancer \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.20989","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T14:22:09Z","timestamp":1154528529000},"page":"486-490","source":"Crossref","is-referenced-by-count":68,"title":["Protocol\u2010based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology\/Oncology (MISPHO)\u2014Part II"],"prefix":"10.1002","volume":"48","author":[{"given":"Scott C.","family":"Howard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Fulgencio","family":"Baez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Cabanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Barrantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lica","family":"Samudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Vizcaino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rodr\u00edguez\u2010Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald D.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino","family":"Conter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Masera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the MISPHO Consortium Writing Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,21]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70246-X"},{"key":"e_1_2_4_3_2","first-page":"1604","volume-title":"Principles and practice of pediatric oncology","author":"Barr RD","year":"2006"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200011000-00005"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.20.2471"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14228-6"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(05)80206-9"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(03)90458-1"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20116"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200011000-00004"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03670.x"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20254"},{"key":"e_1_2_4_13_2","first-page":"219","article-title":"The Monza's International School of Pediatric Hematology\u2010Oncology (MISPHO) for countries with limited resources: A three year experience","volume":"32","author":"Masera G","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07077-9"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50375"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.06.003"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-911X(20010201)36:2<305::AID-MPO1069>3.0.CO;2-K"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(05)70091-4"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.111331"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9667"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.12.2427"},{"key":"e_1_2_4_22_2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.1988.6.4.654","article-title":"Tumor response and toxicity after single high\u2010dose versus standard five\u2010day divided\u2010dose dactinomycin in childhood rhabdomyosarcoma","volume":"6","author":"Carli M","year":"1988","journal-title":"J Clin Oncol"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.610"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.1.171"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008200210674"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/08880019509029583"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3736"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402046"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.191"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403188"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00836.x"},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.04.016"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200401000-00011"},{"key":"e_1_2_4_34_2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2223\/1266","article-title":"Delayed diagnosis in retinoblastoma","volume":"80","author":"Rodrigues KE","year":"2004","journal-title":"J Pediatr (Rio J)"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3370"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200411000-00012"},{"key":"e_1_2_4_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200407000-00014"},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058354"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.20989","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.20989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T16:03:13Z","timestamp":1697644993000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.20989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,21]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1002\/pbc.20989"],"URL":"https:\/\/doi.org\/10.1002\/pbc.20989","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,21]]}}}